NCT02294942View on ClinicalTrials.gov

Extended-Release RANCAD in the Patients With Stable Angina Pectoris

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Stable Angina Pectoris
Interventions
DRUG

RANCAD

Extended-Release RANCAD

Trial Locations (6)

104

Mackay Memorial Hospital, Taipei

111

Shin Kong WuHoSu Memorial Hospital, Taipei

220

Far Eastern Memorial Hospital, New Taipei City

333

Linkou Chang Gung Memorial Hospital, Taoyuan District

Unknown

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

TSH Biopharm Corporation Limited

INDUSTRY

NCT02294942 - Extended-Release RANCAD in the Patients With Stable Angina Pectoris | Biotech Hunter | Biotech Hunter